Safety And Cost Of Infliximab For The Treatment Of Belgian Pediatric Patients With Crohn’s Disease

De Greef, E; Hoffman, I; D'haens, G; Van Biervliet, S; Smets, F; Scaillon, M; De Wit, O; Peeters, H; Paquot, I; Alliet, P; Arts, W; Hauser, B; Vermeire, S; Van Gossum, A; Rahier, Jean-François; Etienne, I; Louis, Edouard; Coche, J C; Mahachie John, Jestinah; Van Steen, Kristel; Veereman, G

Request a copy

Other (Scientific journals)

Safety And Cost Of Infliximab For The Treatment Of Belgian Pediatric Patients With Crohn’s Disease

De Greef, E; Hoffman, I; D'haens, G et al.

2012 • In Journal of Crohn's and Colitis

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/144438

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Safety and cost of infliximab for the treatment of Belgian pediatric patients with Crohn.doc

Publisher postprint (30.21 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Gastroenterology & hepatology

Author, co-author :

De Greef, E

Hoffman, I

D'haens, G

Van Biervliet, S

Smets, F

Scaillon, M

De Wit, O

Peeters, H

Paquot, I

Alliet, P

More authors (11 more)

Language :

English

Title :

Safety And Cost Of Infliximab For The Treatment Of Belgian Pediatric Patients With Crohn’s Disease

Publication date :

2012

Journal title :

Journal of Crohn's and Colitis

ISSN :

1873-9946

eISSN :

1876-4479

Publisher :

Elsevier, United Kingdom

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 09 March 2013

Statistics

Number of views

96 (7 by ULiège)

Number of downloads

3 (3 by ULiège)

More statistics